Does HUMAN C1-ESTERASE INHIBITOR Cause Contraindicated product administered? 472 Reports in FDA Database

Q: Does HUMAN C1-ESTERASE INHIBITOR cause Contraindicated product administered?

472 reports of Contraindicated product administered have been filed with the FDA for HUMAN C1-ESTERASE INHIBITOR, representing 3.3% of all HUMAN C1-ESTERASE INHIBITOR adverse event reports.

Q: How dangerous is Contraindicated product administered from HUMAN C1-ESTERASE INHIBITOR?

Of 472 reports, 465 (98.5%) resulted in death and 391 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 472 reports of Contraindicated product administered have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 3.3% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.

472

Reports of Contraindicated product administered with HUMAN C1-ESTERASE INHIBITOR

3.3%

of all HUMAN C1-ESTERASE INHIBITOR reports

465

Deaths

391

Hospitalizations

How Dangerous Is Contraindicated product administered From HUMAN C1-ESTERASE INHIBITOR?

Of the 472 reports, 465 (98.5%) resulted in death, 391 (82.8%) required hospitalization, and 391 (82.8%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 472 reports have been filed with the FAERS database.

What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?

Hereditary angioedema (5,572) No adverse event (1,660) Off label use (1,614) Drug ineffective (1,426) Intentional product use issue (1,117) Product use in unapproved indication (1,003) Weight increased (897) Maternal exposure during pregnancy (869) Pain (822) Condition aggravated (775)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Contraindicated product administered Risk?

HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE

HUMAN C1-ESTERASE INHIBITOR Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered HUMAN C1-ESTERASE INHIBITOR Demographics